Healthcare Global Enterprises' Q4 FY 2025-26 Quarterly Results

Result Summary

• Healthcare Global Enterprises Ltd reported a 4.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 11.8%.
• Its expenses for the quarter were up by 0.6% QoQ and 8.8% YoY.
• The net profit decreased 151.1% QoQ and decreased 40.3% YoY.
• The earnings per share (EPS) of Healthcare Global Enterprises Ltd stood at 0.15 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Healthcare Global Enterprises Ltd is primarily involved in the healthcare sector, offering specialty healthcare services with a focus on cancer care. The company operates through a network of hospitals and cancer centers across India, providing a range of medical services, including advanced diagnostic and treatment facilities. As a leading player in the healthcare industry, Healthcare Global Enterprises Ltd has been known for its commitment to improving patient care through innovative technologies and comprehensive care services. While specific recent developments aren't provided, companies in this sector often engage in expansion of facilities, introduction of new treatment technologies, or collaborations with other healthcare providers.

Revenue

In the fourth quarter of the fiscal year 2026 (Q4FY26), Healthcare Global Enterprises Ltd reported a total income of ₹665.40 crores. This represented a quarter-over-quarter (QoQ) increase of 4.7% from the preceding quarter (Q3FY26), where total income was ₹635.54 crores. On a year-over-year (YoY) basis, there was an 11.8% increase in total income compared to Q4FY25, which stood at ₹595.39 crores. The upward trend in total income suggests growth over both the previous quarter and the same period in the previous year.

Profitability

In terms of profitability, the company recorded a profit before tax of ₹0.73 crores in Q4FY26, a significant improvement from the loss of ₹6.02 crores in Q3FY26. However, this was a decrease compared to the profit of ₹13.71 crores reported in Q4FY25. The tax component for Q4FY26 was noted as a negative ₹2.79 crores, contributing to a profit after tax of ₹4.04 crores, which contrasts with a loss of ₹7.90 crores in the previous quarter but is lower than the profit of ₹6.77 crores in the same quarter of the previous year. The earnings per share (EPS) for Q4FY26 was ₹0.15, reversing the negative EPS of ₹-0.68 in Q3FY26, although lower than the ₹0.52 reported in Q4FY25.

Operating Metrics

Total expenses for Healthcare Global Enterprises Ltd in Q4FY26 were ₹632.76 crores, which reflects a marginal QoQ increase of 0.6% from ₹628.89 crores in Q3FY26. This also marks a YoY increase of 8.8% from ₹581.68 crores in Q4FY25. The significant improvement in profit after tax from Q3FY26 to Q4FY26, despite a rise in expenses, can be attributed to the negative tax component in the latest quarter. While the specific financial ratios such as P/E ratio, debt-to-equity ratio, or current ratio are not provided, these figures would typically provide insights into the company's valuation, financial leverage, and liquidity, respectively. The trends in total expenses and profitability indicate variations in operating efficiency and cost management over the periods analyzed.